期刊文献+

冠心病二级预防中抗衣原体治疗无益

下载PDF
导出
摘要 肺炎衣原体(Cpn)感染可能参与动脉粥样硬化(AS)的发生发展,但针对肺炎衣原体的抗生素治疗在冠心病的二级预防中是否有效仍是一个悬而未决的问题。目前的研究表明,Cpn可能是AS的启动因素,但并不参与其发生、发展。大规模临床试验并没有得出抗衣原体治疗使冠心病患者获益的结论。
出处 《国际心血管病杂志》 2006年第4期257-260,共4页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献16

  • 1[1]Gupta S.Chronic infection in the aetiology of atherosclerosis-focus on Chlamydia pneumoniae[J].Atherosclerosis,1999,143(1):1-6.
  • 2[2]Kalayoglu MV,Byrne GI.Induction of macrophage foam cell formation by Chlamydia pneumoniae[J].J Infect Dis,1998,177(3):725-729.
  • 3[3]Ridker PM,Kundsin RB,Stampfer MJ,et al.Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction[J].Circulation,1999,99(9):1161-1164.
  • 4[4]Patel P,Carrington D,Strachan DP,et al.Fibrinogen:a link between chronic infection and coronary heart disease[J].Lancet,1994,343(8913):1634-1635.
  • 5[5]Dechend R,Maass M,Gieffers J,et al.Chlamydia pneu moniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression:a potential link to accelerated arteriosclerosis[J].Circulation,1999,100(13):1369-1373.
  • 6[6]Xu Q,Schett G,Perschinka H,et al.Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population[J].Circulation,2000,102(1):14-20.
  • 7[7]Muhlestein JB,Anderson JL,Carlquist JF,et al.Randomized secondary prevention trial of azithromycin in patients with coronary artery disease:primary clinical results of the ACADEMIC study[J].Circulation,2000,102 (15):1755-1760.
  • 8[8]Gupta S,Leatham EW,Carrington D,et al.Elevated Chlamydia pneumoniae antibodies,cardiovascular events,and azithromycin in male survivors of myocardial infarction[J].Circulation,1997,96 (2):404-407.
  • 9[9]O'Connor CM,Dunne MW,Pfeffer MA,et al.Azithromycin for the secondary prevention of coronary heart disease events:the WIZARD study:a randomized controlled trial[J].JAMA,2003,290(11):1459-1466.
  • 10[10]Grayston JT,Kronmal RA,Jackson LA,et al.Azithromycin for the secondary prevention of coronary events[J].N Engl J Med,2005,352(16):1637-1645.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部